Cholesterol‐conjugated miR‐29b induces fetal haemoglobin expression via γ‐globin promoter demethylation in the Townes mouse model for sickle cell anaemia
British Journal of Haematology · 2025
DOI: 10.1111/bjh.20107 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Chithra D Palani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, Department of Pediatrics, Augusta University, Augusta, Georgia, USA. Hauptthemen laut MEDLINE: MicroRNAs, gamma-Globins, Fetal Hemoglobin, Anemia, Sickle Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Cholesterol‐conjugated miRNA has emerged as a viable system for preventing small molecule degradation in plasma with low toxicity and high delivery efficiency. We previously established that miR‐29b induces fetal haemoglobin (HbF) in Townes sickle cell anaemia (SCA) mice using a continuous infusion mini‐osmotic pump. Herein, we expanded the scope of our work to determine the ability of intermittent subcutaneous cholesterol‐conjugated miR‐29b (Chol‐miR‐29b) to induce HbF expression in SCA mice. Blood was collected for automated complete blood counts with differential, reticulocyte count and γ‐globin and β S ‐globin mRNA levels quantified by reverse transcription‐quantitative PCR; flow cytometry measured the percentage of HbF‐positive cells (F‐cells). Methylation assays determined 5‐methylcytosine levels, and RNA sequencing changes in gene expression for different treatment conditions. SCA mice receiving Chol‐miR‐29b exhibited normal behaviour and weight gain without peripheral blood count toxicity. The γ‐globin mRNA levels significantly increased, and F‐cell percentages were enhanced after Chol‐miR‐29b treatment. Subsequently, spleen tissue confirmed decreased DNMT3A protein and 5‐methylcytosine levels in the γ‐globin gene promoter. RNA‐seq analysis supports oncogene silencing and tumour suppressor gene activation by Chol‐miR‐29b. These data demonstrate that a daily subcutaneous dose of Chol‐miR‐29b induces HbF expression, highlighting its potential for clinical development in SCA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology/Oncology, Department of Pediatrics, Augusta University, Augusta, Georgia, USA.
- Department of Genetics, Genomics and Informatics, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
- Department of Health Promotion and Disease Prevention, College of Nursing, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
- Department of Biochemistry and Molecular Biology, Augusta University, Augusta, Georgia, USA.
ORCID-Profile: Betty S Pace, Athena Starlard-Davenport
Förderung
- NHLBI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Palani, C. D., Smith, A., Cao, X., Li, B., Pace, B. S., & Starlard-Davenport, A. (2025). Cholesterol‐conjugated miR‐29b induces fetal haemoglobin expression via γ‐globin promoter demethylation in the Townes mouse model for sickle cell anaemia. British Journal of Haematology. https://doi.org/10.1111/bjh.20107
Vancouver
Palani CD, Smith A, Cao X, Li B, Pace BS, Starlard-Davenport A. Cholesterol‐conjugated miR‐29b induces fetal haemoglobin expression via γ‐globin promoter demethylation in the Townes mouse model for sickle cell anaemia. British Journal of Haematology. 2025. doi:10.1111/bjh.20107
BibTeX
@article{Palani2025,
author = {Palani, Chithra D and Smith, Alana and Cao, Xueyuan and Li, Biaoru and Pace, Betty S and Starlard-Davenport, Athena},
title = {Cholesterol‐conjugated miR‐29b induces fetal haemoglobin expression via γ‐globin promoter demethylation in the Townes mouse model for sickle cell anaemia},
journal = {British Journal of Haematology},
year = {2025},
doi = {10.1111/bjh.20107}
}
EUVIMED